Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02707094 · ClinicalTrials.gov registry record · NA

A Pilot Study Examining the Efficacy of Biomodulator Treatment for Chronic Low Back Pain

A NA study, sponsored by Brooke Army Medical Center.

Completed
Registry status
NA
Development phase
75
Enrollment target

NCT02707094 is a NA study that has completed, run by Brooke Army Medical Center. The registered enrollment target is 75 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02707094, a NA study, has completed, sponsored by Brooke Army Medical Center.

COMPLETED
Registry status
NA
Development phase
75 participants
Enrollment target

Study Summary

The purpose of this study is to determine the efficacy of self treatment with the Biomodulator device to decrease chronic low back pain (LBP) in active duty service members. In addition, the study will track the use of pain medication and the impact of pain on symptoms of anxiety, depression and Post Traumatic Stress Syndrome (PTSD).

Interventions

  • DEVICE Biomodulator
  • OTHER Usual Care (Medication + Exercise)

Trial Details

FieldValue
Enrollment Target 75 participants
Start Date 2013-01
Est. Completion 2016-08-31
Phase NA

Sponsor

Brooke Army Medical Center

54 total trials

What the Registry Record Tells You About NCT02707094

The ClinicalTrials.gov registry entry for NCT02707094 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brooke Army Medical Center, which has 54 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Biomodulator is the first listed.

NCT02707094 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02707094 about?

NCT02707094 is a clinical study titled "A Pilot Study Examining the Efficacy of Biomodulator Treatment for Chronic Low Back Pain". The purpose of this study is to determine the efficacy of self treatment with the Biomodulator device to decrease chronic low back pain (LBP) in active duty service members. In addition, the study will track the use of pain medication and the impact of pain on symptoms of anxiety, depression and Pos...

What is the current status of trial NCT02707094?

This trial is currently completed. It is a NA study. The enrollment target is 75 participants. The study started on 2013-01. Estimated completion is 2016-08-31.

What interventions are being tested in trial NCT02707094?

The interventions under investigation include: Biomodulator (DEVICE), Usual Care (Medication + Exercise) (OTHER).

Who is sponsoring clinical trial NCT02707094?

This trial is sponsored by Brooke Army Medical Center, which has 54 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.